News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
93 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (3)
2 (126)
3 (109)
4 (46)
5 (53)
6 (70)
7 (2)
8 (3)
9 (93)
10 (97)
11 (67)
12 (115)
13 (23)
16 (45)
17 (61)
18 (207)
19 (143)
20 (33)
21 (1)
22 (1)
23 (48)
24 (107)
25 (87)
26 (242)
27 (149)
29 (6)
30 (263)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
16
17
18
19
20
21
22
23
24
25
26
27
29
30
Business
Newest Clinic Opens Today at The Villages in Central Florida
U.S. Stem Cell, Inc. announced the opening its first USRM clinic in North Central Florida.
April 9, 2018
·
3 min read
Business
Henry Schein Names Mark Hillebrandt Vice President, Marketing, North America Dental Group
Henry Schein, Inc. announced that Mark Hillebrandt has joined the company in a newly created position, as Vice President, Marketing, North America Dental Group.
April 9, 2018
·
3 min read
Business
Intezyne Promotes Bradford Sullivan, PhD to Director, CMC
Intezyne announced that it has promoted Bradford Sullivan, PhD to Director, Chemistry, Manufacturing, and Controls (CMC).
April 9, 2018
·
1 min read
Biotech Bay
Varian Launches Velocity 4.0 Cancer Imaging Software with Selective Internal Radiation Therapy Dosimetry Analysis
Software has received FDA 510(k) clearance.
April 9, 2018
·
2 min read
Business
FDNA Expands Leadership Team with Addition of Chief Medical Officer and Chief Data Science Officer
FDNA, developer of the Face2Gene suite of next-generation phenotyping (NGP) applications, announces at the American College of Medical Genetics and Genomics annual meeting the appointment of Dr. Karen Gripp to Chief Medical Officer and Dr. Peter Krawitz to Chief Data Science Officer.
April 9, 2018
·
4 min read
Drug Development
Protalex Initiates Fourth Cohort Dosing of Phase 1/2 Study of PRTX-100 in Immune Thrombocytopenia
Additional study sites opened in the U.K. for the 202 Study
April 9, 2018
·
4 min read
Business
Allogene Therapeutics Completes Agreement for Pfizer’s Allogeneic CAR T Immuno-oncology Portfolio
Gilead Sciences Joins Premier Series A Investment Consortium of TPG, Vida Ventures, BellCo Capital, the University of California Office of the Chief Investment Officer, and Pfizer
April 9, 2018
·
3 min read
Business
Pneuma Respiratory, Inc. Appoints Dr. Steven Kesten President and Chief Medical Officer
Pneuma Respiratory, Inc. has recruited Dr. Steven Kesten as President and Chief Medical Officer.
April 9, 2018
·
2 min read
Business
HRT Center Offers Life Changing HGH Therapy Program in Miami Florida
Human Growth Hormone therapy is known for its benefits in helping those with a deficiency of this hormone.
April 9, 2018
·
2 min read
Drug Development
Upadacitinib Meets All Primary and Ranked Secondary Endpoints Including Superiority Versus Adalimumab in Phase 3 Study in Rheumatoid Arthritis
Upadacitinib significantly inhibited radiographic progression at week 26 compared to placebo
April 9, 2018
·
16 min read
Previous
3 of 10
Next